nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Acupuncture
|
Ernst, Edzard |
|
2010 |
11 |
1 |
p. 20- 1 p. |
artikel |
2 |
Adrian Mole: The Prostrate Years
|
Burki, Talha |
|
2010 |
11 |
1 |
p. 19- 1 p. |
artikel |
3 |
Autosomal-dominant inheritance of hyperphosphorylated paratarg-7
|
Grass, Sandra |
|
2010 |
11 |
1 |
p. 12- 1 p. |
artikel |
4 |
Chemoradiotherapy for locally advanced head and neck cancer: 10-year follow-up of the UK Head and Neck (UKHAN1) trial
|
Tobias, Jeffrey S |
|
2010 |
11 |
1 |
p. 66-74 9 p. |
artikel |
5 |
Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study
|
Zhu, Andrew X |
|
2010 |
11 |
1 |
p. 48-54 7 p. |
artikel |
6 |
Errata
|
|
|
2010 |
11 |
1 |
p. 14- 1 p. |
artikel |
7 |
Errata
|
|
|
2010 |
11 |
1 |
p. 14- 1 p. |
artikel |
8 |
Evidence-based organ-sparing radiotherapy in head and neck cancer
|
Dirix, Piet |
|
2010 |
11 |
1 |
p. 85-91 7 p. |
artikel |
9 |
First-generation genomic tests for breast cancer treatment
|
Andre, Fabrice |
|
2010 |
11 |
1 |
p. 6-7 2 p. |
artikel |
10 |
Harnessing personalised medicine to prevent late effects
|
Ganz, Patricia A |
|
2010 |
11 |
1 |
p. 7-9 3 p. |
artikel |
11 |
Improved first-line chemotherapy: a better chance for surgery?
|
Tejpar, Sabine |
|
2010 |
11 |
1 |
p. 4-5 2 p. |
artikel |
12 |
Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial
|
Rajkumar, S Vincent |
|
2010 |
11 |
1 |
p. 29-37 9 p. |
artikel |
13 |
More woes for UK cancer services
|
The Lancet Oncology, |
|
2010 |
11 |
1 |
p. 1- 1 p. |
artikel |
14 |
Population-based differences in treatment outcome following anticancer drug therapies
|
Ma, Brigette BY |
|
2010 |
11 |
1 |
p. 75-84 10 p. |
artikel |
15 |
Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive, oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial
|
Albain, Kathy S |
|
2010 |
11 |
1 |
p. 55-65 11 p. |
artikel |
16 |
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
|
Bonner, James A |
|
2010 |
11 |
1 |
p. 21-28 8 p. |
artikel |
17 |
Rash conclusions from a phase 3 study of cetuximab?
|
Harrington, Kevin J |
|
2010 |
11 |
1 |
p. 2-3 2 p. |
artikel |
18 |
51st ASH annual meeting
|
Brierley, Rob |
|
2010 |
11 |
1 |
p. 18- 1 p. |
artikel |
19 |
Targeted therapy for biliary-tract cancer
|
Furuse, Junji |
|
2010 |
11 |
1 |
p. 5-6 2 p. |
artikel |
20 |
The Lancet Oncology to publish more research in 2010
|
Collingridge, David |
|
2010 |
11 |
1 |
p. 11-12 2 p. |
artikel |
21 |
Time to raise the bar for cancer drug approval?
|
Mayor, Susan |
|
2010 |
11 |
1 |
p. 16-17 2 p. |
artikel |
22 |
Towards a new standard of care for patients with myeloma?
|
Palumbo, Antonio |
|
2010 |
11 |
1 |
p. 3-4 2 p. |
artikel |
23 |
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial
|
Folprecht, Gunnar |
|
2010 |
11 |
1 |
p. 38-47 10 p. |
artikel |
24 |
Tumour tissue: who is in control?
|
Ploem, Martine Corrette |
|
2010 |
11 |
1 |
p. 9-11 3 p. |
artikel |
25 |
Use of new imaging techniques to predict tumour response to therapy
|
Harry, Vanessa N |
|
2010 |
11 |
1 |
p. 92-102 11 p. |
artikel |
26 |
US evidence-based medicine faces uphill battle
|
Furlow, Bryant |
|
2010 |
11 |
1 |
p. 15- 1 p. |
artikel |
27 |
Whole-brain radiation therapy in melanoma: an open question
|
Cranmer, Lee D |
|
2010 |
11 |
1 |
p. 13- 1 p. |
artikel |
28 |
Whole-brain radiation therapy in melanoma: an open question – Authors' reply
|
Chang, Eric L |
|
2010 |
11 |
1 |
p. 13-14 2 p. |
artikel |